However, as with any injection, some individuals may experience mild side effects: Injection site reactions: Mild soreness, redness, or swelling at the injection site is the most common side effect
For weight management , certain GLP-1 formulations (liraglutide 3.0mg [Saxenda] and semaglutide 2.4mg [Wegovy]) are licensed for chronic weight management in adults with: BMI 30 kg/m , or BMI 27 kg/m with at least one weight-related comorbidity (such as type 2 diabetes, hypertension, or dyslipidaemia) However, NHS access to these medications for weight management is typically restricted to specialist tier 3 or tier 4 weight management services, with specific eligibility criteria defined by NICE technology appraisals (TA494 for liraglutide, TA664 for semaglutide) and local commissioning arrangements
After reconstituting: Refrigerate between 2C and 8C
This hydroxylated intermediate is crucial for the subsequent cleavage and oxidation steps
Hims & Hers do not require lab work to begin or continue treatment